Buffalo, NY, United States of America

Mikhail Nikiforov

This inventor holds 1 USPTO granted patent. Top assignees: Children's Cancer Institute Australia for Medical Research, Health Research, Inc., Panacela Labs, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikhail Nikiforov. Retrieved from https://idiyas.com/inventor/mikhail-nikiforov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Mikhail Nikiforov: Revolutionizing Technology in Buffalo

Introduction: Mikhail Nikiforov is a visionary inventor based in Buffalo, NY, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mikhail Nikiforov holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Nikiforov has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Mikhail Nikiforov has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Mikhail Nikiforov's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field of inventions, with his work continuing to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…